Topical hair growth formulation
AssigneeSynergistic Therapeutics, LLC
InventorsAnthony H. Salce, Jr., William F. Greenwood, Shivsankar Misir
Life of this patent
Estimating the term…
Abstract
Technologies are described for a formulation and production of a formulation. The methods may comprise depositing a non-steroidal anti-inflammatory drug (NSAID) compound, a calcium channel blocker, an immunosuppressive component, an anti-hypertensive, a hormone, a steroid, and an enzyme inhibitor into a chamber. The methods may comprise milling and mixing the NSAID compound, the calcium channel blocker, the immunosuppressive component, the anti-hypertensive, the hormone, the steroid, and the enzyme inhibitor into a powder. The methods may comprise adding a solvent with the powder. The methods may comprise mixing the solvent with the powder to form the formulation.
Claims20
A formulation comprising:
- a non-steroidal anti-inflammatory drug (NSAID);
- a calcium channel blocker;
- an immunosuppressive component;
- an anti-hypertensive;
- a hormone;
- a steroid;
- and
- an enzyme inhibitor.
A method to produce a formulation, the method comprising:
- receiving a non-steroidal anti-inflammatory drug (NSAID) compound into a chamber;
- receiving a calcium channel blocker into the chamber;
- receiving a calcium channel blocker into the chamber;
- receiving an immunosuppressive component into the chamber;
- receiving an anti-hypertensive into the chamber;
- receiving a hormone into the chamber;
- receiving steroid into the chamber;
- receiving an enzyme inhibitor into the chamber;
- milling the NSAID compound, the calcium channel blocker, the immunosuppressive component, the anti-hypertensive, the hormone, the steroid, and the enzyme inhibitor into a powder.
A formulation comprising:
- 2.0 to 10.0 weight percent of a non-steroidal anti-inflammatory drug (NSAID);
- 0.01 to 0.05 weight percent of a calcium channel blocker;
- 0.5 to 1.0 weight percent of an immunosuppressive component;
- 3.0 to 7.0 weight percent of an anti-hypertensive;
- 0.005 to 0.010 weight percent of a hormone;
- and
- 0.1 to 0.2 weight percent of a steroid.
Dependencies are inferred from the claim text.